C igarette smoking is a major, preventable cause of cardiovascular diseases, particularly of coronary artery disease. 1 Epidemiological studies have suggested that active smoking is associated with incident heart failure in general populations, even after accounting for potential confounders and coronary artery disease. 2,3 Nevertheless, the mechanisms linking cigarette smoking to cardiac dysfunction are not established. 4
Smoking and Echocardiography
The original cohort included 15 792 participants aged 45 to 64 years recruited between 1987 and 1989 (visit 1), selected from 4 communities in the United States: Forsyth County, North Carolina; Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington County, Maryland. Institutional review boards from each site approved the study, and informed consent was obtained from all participants. In this study, we considered the 6538 surviving participants attending visit 5 (2011-2013) . We excluded those with prevalent coronary artery disease, heart failure, or moderate or severe valvular disease (n=1187) and participants whose race was neither black nor white (n=14) or with missing echocardiographic examination (n=304) or smoking data (n=453), resulting in 4580 individuals eligible for the present analysis.
Measurements

Smoking History
Smoking history was ascertained by means of an interviewer-administered questionnaire. At visit 5, participants were asked whether they currently smoked cigarettes or whether they had done so in the past. This approach yielded 3 categories: never smokers, former smokers, and current smokers. Cumulative pack-years and years of smoking were available up to visit 4 (1996-1998) , whereas between visit 4 and visit 5, the participant smoking status (current smoker/non smoker) was ascertained by annual follow-up evaluations without assessment of intensity of smoking. As a result, the cumulative exposure to smoking up to visit 5 was estimated by assuming that smoking intensity obtained at visit 4 persisted over the interval from visit 4 to visit 5 among those who continued to smoke, allowing for the estimation of pack-years between visit 4 to visit 5 by multiplying the number of cigarettes/d at visit 4 by the number of years smoked between visits 4 and 5.
Echocardiography Protocol
The echocardiographic imaging and analysis protocol has been previously described in detail. 18 All studies were acquired at visit 5 on Philips IE33 machines (Philips, Andover, MA) by trained sonographers. Analyses were performed by expert technicians and overread by echocardiographers in a central echo core laboratory. LV mass was indexed to body surface area, and LV hypertrophy was defined as LV mass index >115 g/m 2 in men or >95 g/m 2 in women. Normal LV mass index or LV hypertrophy coupled with relative wall thickness ≥0.42 was defined as concentric remodeling or concentric hypertrophy, respectively, whereas normal LV mass index or LV hypertrophy coupled with relative wall thickness <0.42 was considered normal ventricular structure or eccentric hypertrophy, respectively. 19 Left atrial volume was indexed to body surface area. Peak lateral and septal mitral annular relaxation (E′) velocities were assessed using tissue Doppler imaging. Right ventricular function was assessed using the tricuspid annular peak systolic velocity, and right ventricular fractional area change was calculated as the percent change in cavity area. Global longitudinal strain was derived from speckle-tracking echocardiography.
Measurement of Other Baseline Covariates
Information on demographics, clinical history, anthropomorphic measures, and blood pressure was obtained at the time of echocardiography. Definitions for hypertension, diabetes mellitus, current alcohol consumption, coronary artery disease, and heart failure were used as previously described in the ARIC study. 20 Low-density and highdensity lipoprotein cholesterol levels were measured in a centralized laboratory. Carotid-femoral pulse wave velocity was measured using a ColinVP-1000 plus system (Omron Co, Komaki, Japan). 21
Statistical Methods
Descriptive data are presented as the mean±SD for normally distributed variables and median (25th-75th percentile) for non-normally distributed variables. Categorical variables are expressed as proportions. Significant pairwise comparisons are shown only for variables in which a significant global difference was detected using 1-way ANOVA or Kruskal-Wallis tests. The χ 2 test was used to compare categorical variables. Echocardiographic data are presented as multivariable adjusted means with P values estimated from linear or logistic regression across smoking categories. Multivariate model covariates were selected based on a priori knowledge. Two regression models were constructed: model 1 included age, sex, and race; model 2 additionally adjusted for diabetes mellitus, antihypertensive medications, body mass index, systolic blood pressure, current alcohol consumption, heart rate, and carotid-femoral pulse wave velocity. Linear regression analysis between echocardiographic parameters and packyears of smoking or years of smoking was performed adjusting for model 2 covariates and included never (0 pack-years) and current smokers. To further quantify the impact of possible bias because of selective attrition before visit 5 because of nonattendance among living cohort participants, we calculated inverse probability weights 22, 23 to estimate the likelihood of visit 5 participation among cohort participants known to be alive on December 31, 2011. Nonattendance to visit 5 was modeled using the following variables assessed at visit 1: age, sex, race, field center, diabetes mellitus, body mass index, hypertension, systolic blood pressure, heart rate, estimated glomerular filtration rate, and smoking status. The inverse of these resulting estimated probabilities were used as weights so that, in order to better represent the full ARIC population, visit 5 attendees with characteristics more similar to those who did not attend were given more weight in subsequent analyses of associations with echocardiographic analyses. Tests for interaction were performed using the likelihood ratio test for the cross-product interaction term between sex, race, and measures of cardiac structure and function. Two-sided P values <0.05 were considered significant. Analyses were performed using Stata version 13.1 (Stata Corp, College Station, TX).
Results
Among the 4580 ARIC visit 5 participants included in this analysis, 287 (6.3%) were current smokers, 2316 (50.5%) were former smokers and 1977 (43.2%) never smoked. Table 1 illustrates the characteristics of the study population according to smoking status. Never smokers were more likely to be women, were less frequently alcohol drinkers, and had higher, low-density and high-density lipoprotein cholesterol levels compared with the other smoking groups. Current smokers were younger, had lower average body mass index, and had higher estimated glomerular filtration rate than the other smoking groups. Moreover, they were more likely to be black, women, and had higher pack-years and years of smoking compared with former smokers. Tables 2 and 3 present the associations between smoking status and measures of cardiac structure and function. When compared with never and former smokers, current smokers had greater LV mass index, LV mass/volume ratio, and higher prevalence of LV hypertrophy and concentric LV hypertrophy after adjusting for age, sex, race, body mass index, diabetes mellitus, antihypertensive medications, systolic blood pressure, current alcohol consumption, heart rate, and carotidfemoral pulse wave velocity ( Table 2 ). Current smokers also had worse LV diastolic function, as evidenced by higher E/E′ ratio ( Table 3) . We observed a marginally higher LV ejection fraction in current smokers, but the difference in this variable between current and never smokers became nonsignificant (P=0.07) after additional adjustment for LV mass/volume ratio (Table 3 ). Furthermore, global longitudinal LV strain, which has been reported as a more sensitive measure of systolic function, 24 did not differ among the smoking groups. Lastly, no significant association between right ventricular structural and functional features and smoking status was detected.
Estimated pack-years and years of smoking, which are measures of cumulative cigarette exposure, were associated with greater LV mass index, LV mass/volume ratio, and worse diastolic function (higher E/E′ ratio) in multivariable analysis (Figure) .
To account for possible bias because of selective attrition before visit 5 because of nonattendance among living cohort participants, we included estimated inverse probability of attendance as weights in the multivariable models (Tables I  and II in the Data Supplement). This approach did not change the associations between smoking variables and echocardiographic parameters, except for the differences in the prevalence of LV concentric hypertrophy between current and never smokers, which became nonsignificant after applying calculated inverse probability weights. We did not find any significant interaction by sex and race for the relationship between smoking and cardiac structural and functional features. Lastly, further adjustment for spirometric markers of lung function obtained at visit 5 (forced vital capacity or forced expiratory volume in 1 second) and markers of socioeconomic status (income and education level) did not exert substantial changes in the association between smoking and echocardiographic parameters.
Discussion
In a large sample of elderly individuals free of overt coronary artery disease and heart failure, current smokers had higher LV mass and LV mass/volume ratio, higher prevalence of LV hypertrophy, and worse diastolic function, as reflected by higher E/E′ ratio, compared with never smokers and former smokers. Furthermore, pack-years and years of smoking were associated with greater LV mass index, LV mass/volume ratio, and worse diastolic function among current and never smokers in multivariable analysis. These findings suggest that active smoking and cumulative cigarette exposure were associated with alterations in LV structure and function.
Elevated LV mass and LV hypertrophy are acknowledged risk factors for heart failure. 25 In the present study, LV mass and prevalence of LV hypertrophy were higher in current smokers compared with never and former smokers. Although previous studies have reported conflicting results, 8, 9 our findings are in agreement with data from other large general populations, [5] [6] [7] which showed greater LV mass in active smokers. The average difference in LV mass between current smokers and nonsmokers in our adjusted analysis was ≈7 g, similar in magnitude to data from the Cardiovascular Health Study, 5 Multi-Ethnic Study of Atherosclerosis, 6 and The Study of Health in Pomerania. 7 Furthermore, we found that current smokers had a higher LV mass/volume ratio and a trend toward higher prevalence of LV concentric hypertrophy in comparison with the other smoking groups, suggesting that active smoking may also favor the development of LV concentricity, a feature that has been related to worse cardiovascular prognosis independent of LV mass. 26 Whether these relatively modest differences in LV geometry and mass can be related to future outcomes remains to be established.
Previous studies showed contradictory results about the relationship between smoking and LV diastolic function in general populations. [12] [13] [14] In addition, significant associations between smoking and impaired LV diastolic function have been reported only in women. 13, 14 In the present report, we found that E/E′ ratio, a marker of LV filling pressure, was elevated in current smokers, and this association was not influenced by sex. Our larger sample size probably increased the ability to detect significant associations in the whole sample, which could account for the differences between our findings and those of previous reports. [12] [13] [14] Overall, these results suggest that active smoking was associated with impaired LV diastolic function, which might help explain the higher risk of incident heart failure reported for smokers in epidemiological studies. 2, 3 Smoking is known to increase the risk of cardiovascular atherosclerotic diseases in a dose-dependent fashion. 27 However, the impact of intensity and duration of cigarette smoking on cardiac structure and function has been uncertain. We found that cumulative cigarette exposure was associated with higher LV mass and worse diastolic function in active smokers. In addition, we observed similar echocardiographic features between former and never smokers, suggesting that the potential effects of tobacco on the myocardium might be reversible after smoking cessation. Nevertheless, it is possible that residual myocardial alterations may persist after smoking cessation, because subtle reductions in LV function 11 and a modestly higher risk of heart failure 3 among former smokers have been reported by others.
In our population, smoking was not associated with global longitudinal LV strain, which has been reported as a more sensitive measure of systolic function, 24 thus suggesting that smoking was not related to significant variations in LV systolic function. We also observed that LV ejection fraction, a less informative measure of systolic function when compared with global longitudinal strain, 24, 28 was marginally higher in current smokers than in the other smoking groups. However, LV ejection fraction may be influenced by cardiac geometry 29 and is known to increase in parallel with LV mass/volume ratio. 30 In accordance with this notion, we found that the difference in LV ejection fraction between current and never smokers became no longer apparent after adjusting for LV mass/volume ratio in multivariable analysis, suggesting that the higher LV ejection fraction seen in current smokers could be more a consequence of variation in LV geometry rather than resulting from enhanced LV systolic function.
A variety of mechanisms might explain the association between smoking and LV remodeling and dysfunction.
Smoking-associated cardiac alterations could be a result of tobacco-induced increases in blood pressure levels 15 or a consequence of coexisting risk factors, such as alcohol consumption. 16 However, we found no differences in brachial blood pressure levels among the smoking groups, and the association between smoking and echocardiographic parameters was independent of blood pressure levels and active alcohol consumption. Previous studies have also hypothesized that the adverse effects of tobacco on the myocardium could be driven by smoking-induced increases in arterial stiffness. 7 In contrast to this hypothesis, we provided novel evidence that the association between smoking and higher LV mass and worse LV function was independent of carotidfemoral pulse wave velocity, an acknowledged marker of arterial stiffness. Lastly, it is possible that the changes in cardiac parameters were a result of direct effects of tobacco on the myocardium. This hypothesis is supported by experimental evidence showing that cigarette smoke may stimulate myocardial hypertrophy and dysfunction, by inducing neurohumoral changes, oxidative stress, and activation of matrix metalloproteinases and mitogen-activated protein kinases. 4 Nevertheless, additional studies are necessary to discern the exact mechanisms by which smoking influences cardiac structure and function. Some limitations of this study should be highlighted. Cigarette smoking information was obtained through interviewer-administered questionnaires, and no validation with biochemical analyses was attempted. Thus, participants may have under-reported their smoking habits, although this would likely have biased our results toward the null. In addition, we estimated the number of pack-years smoked between visits 4 and 5 by assuming that smoking intensity obtained at visit 4 persisted during the interval from visit 4 to visit 5, which might limit the accuracy of total pack-years used in our analyses. However, years of smoking, an alternative measure of smoking burden, 31 was calculated up to visit 5 and showed similar associations with echocardiographic parameters when compared with total pack-years, suggesting that total pack-years used in our analysis may have provided a good estimation of cumulative cigarette exposure. As in any observational crosssectional study, residual confounding cannot be excluded, and the associations observed between smoking and variation in cardiac structure and function cannot be assumed to be causal. In our analysis, we did not account for multiple testing, because such typical corrections for multiplicity (ie, Bonferroni) can be overly conservative in the presence of correlated outcomes, and it is known that in general, echocardiography parameters are not independent of each other. However, all associations between smoking status and echocardiographic parameters (except for the adjusted differences on LV hypertrophy prevalence between current and former smokers) would remain significant considering a Bonferroni level of significance of P<0.05/6 (=0.0083), accounting for 6 echocardiography measures. It is possible that survival bias and selection bias may have influenced our estimates. Given that current smokers have a higher rate of death, incident heart failure, and cardiovascular events compared with never and former smokers, 32 our analysis possibly included only the smokers who were relatively healthier and therefore did not include a substantial number of smokers who had more expressive cardiac remodeling and dysfunction but died before the analysis. This raises the assumption that similar or even greater associations between smoking and adverse cardiac characteristics would have been observed among subjects who did not survive. Conversely, it should be acknowledged that our sample of current smokers, which only included elderly individuals without coronary disease or heart failure, may represent a biologically unique group of individuals, not necessarily reflecting the full spectrum of the smoking population. Furthermore, selective attrition before visit 5 may have introduced biased estimates in our analysis. However, our sensitivity analysis using inverse probability attrition weighting to account for nonattendance among living cohort participants demonstrated consistent results when compared with the primary analysis.
In summary, we found that active smoking and cumulative cigarette exposure were associated with higher LV mass, LV mass/volume ratio, and worse diastolic function in an elderly, community-based population free of overt coronary artery disease and heart failure. These findings suggest that active smoking is associated with subtle alterations in LV structure and function, which might help explain the higher risk of heart failure reported for smokers independent of coronary artery disease.
